EGFR and non-small cell lung carcinoma: A total of 159 patients with baseline EGFR exon 21 L858R mutated NSCLC met the study’s inclusion criteria were enrolled in the study at our center (Cancer center, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China) between Jan 1, 2015, to Jan 1, 2021.